HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and Chief Technical Officer Michael J. Labarre sold $1.2M of Halozyme Therapeutics, Inc.
Sold$1,175,968
$39.93Price
29,450Shares
−17%Stake
What HALO did after the filing
- The stock from Fri, Oct 1 close, $40.75
- −4.4%
- S&P 500, same days
- +7.6%
Measured over 30 trading days, to the Nov 12 close.
Traded Fri, Oct 1. Filed Fri, Oct 1, 3:32 PM ET, during the session. Returns use the Oct 1 close and the Nov 12 close. Not investment advice.